It is anticipated that as is usually the case, financial motivation will move TZ from its current status “potential anti-MDR/XDR agent,” to one that will cure MDR and XDR TB. Foreword.

Leonard Amaral

It is anticipated that as is usually the case, financial motivation will move TZ from its current status “potential anti-MDR/XDR agent,” to one that will cure MDR and XDR TB. Foreword.

Unidade de Parasitologia e Microbiologia Médicas (UPMM)

Research output: Contribution to journal › Article › peer-review

Original language	Unknown
Journal	Recent Patents On Anti-Infective Drug Discovery
Volume	6
Publication status	Published - 1 Jan 2011

Cite this

@article{93ea6c1a7493440ea3cd4fc80892f3d6,

title = "It is anticipated that as is usually the case, financial motivation will move TZ from its current status “potential anti-MDR/XDR agent,” to one that will cure MDR and XDR TB. Foreword.",

author = "Leonard Amaral",

year = "2011",

month = jan,

day = "1",

language = "Unknown",

volume = "6",

journal = "Recent Patents On Anti-Infective Drug Discovery",

issn = "1574-891X",

publisher = "Bentham Science Publishers",

}

TY - JOUR

T1 - It is anticipated that as is usually the case, financial motivation will move TZ from its current status “potential anti-MDR/XDR agent,” to one that will cure MDR and XDR TB. Foreword.

AU - Amaral, Leonard

PY - 2011/1/1

Y1 - 2011/1/1

M3 - Article

C2 - 21796848

SN - 1574-891X

VL - 6

JO - Recent Patents On Anti-Infective Drug Discovery

JF - Recent Patents On Anti-Infective Drug Discovery

ER -